» Articles » PMID: 27592330

Symptom Burden in Heart Failure: Assessment, Impact on Outcomes, and Management

Overview
Journal Heart Fail Rev
Date 2016 Sep 5
PMID 27592330
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Evidence-based management has improved long-term survival in patients with heart failure (HF). However, an unintended consequence of increased longevity is that patients with HF are exposed to a greater symptom burden over time. In addition to classic symptoms such as dyspnea and edema, patients with HF frequently suffer additional symptoms such as pain, depression, gastrointestinal distress, and fatigue. In addition to obvious effects on quality of life, untreated symptoms increase clinical events including emergency department visits, hospitalizations, and long-term mortality in a dose-dependent fashion. Symptom management in patients with HF consists of two key components: comprehensive symptom assessment and sufficient knowledge of available approaches to alleviate the symptoms. Successful treatment addresses not just the physical but also the emotional, social, and spiritual aspects of suffering. Despite a lack of formal experience during cardiovascular training, symptom management in HF can be learned and implemented effectively by cardiology providers. Co-management with palliative medicine specialists can add significant value across the spectrum and throughout the course of HF.

Citing Articles

London Chest Activity of Daily Living: Reliability and Validity of the European Portuguese Version in Heart Failure Patients.

Oliveira I, Delgado B, Mota C, Gomes I, Ferreira P Healthcare (Basel). 2025; 13(4).

PMID: 39997252 PMC: 11855288. DOI: 10.3390/healthcare13040377.


Palliative care for cardiovascular patients: comparison of the motives of referral by cardiologists and the actual care provided by the mobile palliative care team.

Giffard M, Van Bulck L, Sall F, Becoulet N, Seronde M, Ecarnot F Eur Geriatr Med. 2025; .

PMID: 39922963 DOI: 10.1007/s41999-024-01143-2.


Palliative Care and Hospice for Heart Failure Patients: Position Statement From the Korean Society of Heart Failure.

Lee S, Lee H, Yoo S, Cho H, Youn J, Park S Int J Heart Fail. 2025; 7(1):32-46.

PMID: 39911570 PMC: 11791178. DOI: 10.36628/ijhf.2024.0069.


Relationship between incident cardiovascular disease and quality of life after a breast cancer diagnosis.

Vasbinder A, Wadden E, Cheng R, Barac A, Friese C, Sun Y J Cancer Surviv. 2025; .

PMID: 39909978 DOI: 10.1007/s11764-025-01757-w.


Background and design of the Physical Frailty and Symptom Monitoring and Management Behaviors in Heart Failure (PRISM-HF) study: A mixed methods study.

Denfeld Q, Hiatt S, Rosenkranz S, Camacho S, Chien C, Dieckmann N Int J Nurs Stud Adv. 2025; 8:100282.

PMID: 39811574 PMC: 11732207. DOI: 10.1016/j.ijnsa.2024.100282.


References
1.
Thomas D . Incidence of venous thromboembolism in megestrol acetate users. J Am Med Dir Assoc. 2004; 5(1):65-6. DOI: 10.1097/01.JAM.0000105070.61741.9D. View

2.
Currow D, Abernethy A . Pharmacological management of dyspnoea. Curr Opin Support Palliat Care. 2008; 1(2):96-101. DOI: 10.1097/SPC.0b013e3282ef5e03. View

3.
Zambroski C, Moser D, Bhat G, Ziegler C . Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005; 4(3):198-206. DOI: 10.1016/j.ejcnurse.2005.03.010. View

4.
Howlett J, Morin L, Fortin M, Heckman G, Strachan P, Suskin N . End-of-life planning in heart failure: it should be the end of the beginning. Can J Cardiol. 2010; 26(3):135-41. PMC: 2851467. DOI: 10.1016/s0828-282x(10)70351-2. View

5.
Ballantyne J, Sullivan M . Intensity of Chronic Pain--The Wrong Metric?. N Engl J Med. 2015; 373(22):2098-9. DOI: 10.1056/NEJMp1507136. View